太龍藥業(600222.SH)授權管理層擇機處置所持鄭州銀行股份
格隆匯8月23日丨太龍藥業(600222.SH)公佈,公司2019年8月22日召開第七屆董事會第二十二次會議,審議通過了《關於授權公司管理層處置金融資產的議案》。
截至2019年8月22日,公司持有鄭州銀行股份1000萬股(股票代碼:002936),該部分股份將於2019年9月19日解除限售,上市流通。
為提高公司資產流動性及使用效率,公司董事會同意授權管理層根據公司投資策略、證券市場情況以及公司經營與財務狀況,擇機通過二級市場處置公司持有的上述鄭州銀行股份,授權期限為本議案經董事會審議通過之日起12個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.